The White House on Thursday announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue […]
Incident conditions that may be attributable to COVID-19 are common among adult COVID-19 survivors, according to research published in the May 24 early-release issue of the […]
The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older.